Implantation of inferior vena cava interposition graft in mouse model

Yong Ung Lee, Tai Yi, Shuhei Tara, Avione Y. Lee, Narutoshi Hibino, Toshiharu Shinoka, Christopher K. Breuer

Research output: Contribution to journalArticle

Abstract

Biodegradable scaffolds seeded with bone marrow mononuclear cells (BMCs) are often used for reconstructive surgery to treat congenital cardiac anomalies. The long-term clinical results showed excellent patency rates, however, with significant incidence of stenosis. To investigate the cellular and molecular mechanisms of vascular neotissue formation and prevent stenosis development in tissue engineered vascular grafts (TEVGs), we developed a mouse model of the graft with approximately 1 mm internal diameter. First, the TEVGs were assembled from biodegradable tubular scaffolds fabricated from a polyglycolic acid nonwoven felt mesh coated with ε-caprolactone and L-lactide copolymer. The scaffolds were then placed in a lyophilizer, vacuumed for 24 hr, and stored in a desiccator until cell seeding. Second, bone marrow was collected from donor mice and mononuclear cells were isolated by density gradient centrifugation Third, approximately one million cells were seeded on a scaffold and incubated O/N. Finally, the seeded scaffolds were then implanted as infrarenal vena cava interposition grafts in C57BL/6 mice. The implanted grafts demonstrated excellent patency (>90%) without evidence of thromboembolic complications or aneurysmal formation. This murine model will aid us in understanding and quantifying the cellular and molecular mechanisms of neotissue formation in the TEVG.

Original languageEnglish (US)
Article numbere51632
JournalJournal of Visualized Experiments
Issue number88
DOIs
StatePublished - Jun 4 2014
Externally publishedYes

Fingerprint

Blood Vessel Prosthesis
Inferior Vena Cava
Grafts
Scaffolds
Transplants
Reconstructive Surgical Procedures
Pathologic Constriction
Polyglycolic Acid
Venae Cavae
Density Gradient Centrifugation
Tissue
Inbred C57BL Mouse
Bone Marrow Cells
Blood Vessels
Bone
Bone Marrow
Centrifugation
Incidence
Surgery
Copolymers

Keywords

  • Biodegradable
  • Inferior vena cava
  • Interposition graft
  • Issue 88
  • Medicine
  • Mouse model
  • Tissue engineered vascular graft
  • Tissue engineering

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Chemical Engineering(all)
  • Immunology and Microbiology(all)
  • Neuroscience(all)

Cite this

Lee, Y. U., Yi, T., Tara, S., Lee, A. Y., Hibino, N., Shinoka, T., & Breuer, C. K. (2014). Implantation of inferior vena cava interposition graft in mouse model. Journal of Visualized Experiments, (88), [e51632]. https://doi.org/10.3791/51632

Implantation of inferior vena cava interposition graft in mouse model. / Lee, Yong Ung; Yi, Tai; Tara, Shuhei; Lee, Avione Y.; Hibino, Narutoshi; Shinoka, Toshiharu; Breuer, Christopher K.

In: Journal of Visualized Experiments, No. 88, e51632, 04.06.2014.

Research output: Contribution to journalArticle

Lee, YU, Yi, T, Tara, S, Lee, AY, Hibino, N, Shinoka, T & Breuer, CK 2014, 'Implantation of inferior vena cava interposition graft in mouse model', Journal of Visualized Experiments, no. 88, e51632. https://doi.org/10.3791/51632
Lee, Yong Ung ; Yi, Tai ; Tara, Shuhei ; Lee, Avione Y. ; Hibino, Narutoshi ; Shinoka, Toshiharu ; Breuer, Christopher K. / Implantation of inferior vena cava interposition graft in mouse model. In: Journal of Visualized Experiments. 2014 ; No. 88.
@article{390f0b4128bd45f5972c94a0ab34e47a,
title = "Implantation of inferior vena cava interposition graft in mouse model",
abstract = "Biodegradable scaffolds seeded with bone marrow mononuclear cells (BMCs) are often used for reconstructive surgery to treat congenital cardiac anomalies. The long-term clinical results showed excellent patency rates, however, with significant incidence of stenosis. To investigate the cellular and molecular mechanisms of vascular neotissue formation and prevent stenosis development in tissue engineered vascular grafts (TEVGs), we developed a mouse model of the graft with approximately 1 mm internal diameter. First, the TEVGs were assembled from biodegradable tubular scaffolds fabricated from a polyglycolic acid nonwoven felt mesh coated with ε-caprolactone and L-lactide copolymer. The scaffolds were then placed in a lyophilizer, vacuumed for 24 hr, and stored in a desiccator until cell seeding. Second, bone marrow was collected from donor mice and mononuclear cells were isolated by density gradient centrifugation Third, approximately one million cells were seeded on a scaffold and incubated O/N. Finally, the seeded scaffolds were then implanted as infrarenal vena cava interposition grafts in C57BL/6 mice. The implanted grafts demonstrated excellent patency (>90{\%}) without evidence of thromboembolic complications or aneurysmal formation. This murine model will aid us in understanding and quantifying the cellular and molecular mechanisms of neotissue formation in the TEVG.",
keywords = "Biodegradable, Inferior vena cava, Interposition graft, Issue 88, Medicine, Mouse model, Tissue engineered vascular graft, Tissue engineering",
author = "Lee, {Yong Ung} and Tai Yi and Shuhei Tara and Lee, {Avione Y.} and Narutoshi Hibino and Toshiharu Shinoka and Breuer, {Christopher K.}",
year = "2014",
month = "6",
day = "4",
doi = "10.3791/51632",
language = "English (US)",
journal = "Journal of Visualized Experiments",
issn = "1940-087X",
publisher = "MYJoVE Corporation",
number = "88",

}

TY - JOUR

T1 - Implantation of inferior vena cava interposition graft in mouse model

AU - Lee, Yong Ung

AU - Yi, Tai

AU - Tara, Shuhei

AU - Lee, Avione Y.

AU - Hibino, Narutoshi

AU - Shinoka, Toshiharu

AU - Breuer, Christopher K.

PY - 2014/6/4

Y1 - 2014/6/4

N2 - Biodegradable scaffolds seeded with bone marrow mononuclear cells (BMCs) are often used for reconstructive surgery to treat congenital cardiac anomalies. The long-term clinical results showed excellent patency rates, however, with significant incidence of stenosis. To investigate the cellular and molecular mechanisms of vascular neotissue formation and prevent stenosis development in tissue engineered vascular grafts (TEVGs), we developed a mouse model of the graft with approximately 1 mm internal diameter. First, the TEVGs were assembled from biodegradable tubular scaffolds fabricated from a polyglycolic acid nonwoven felt mesh coated with ε-caprolactone and L-lactide copolymer. The scaffolds were then placed in a lyophilizer, vacuumed for 24 hr, and stored in a desiccator until cell seeding. Second, bone marrow was collected from donor mice and mononuclear cells were isolated by density gradient centrifugation Third, approximately one million cells were seeded on a scaffold and incubated O/N. Finally, the seeded scaffolds were then implanted as infrarenal vena cava interposition grafts in C57BL/6 mice. The implanted grafts demonstrated excellent patency (>90%) without evidence of thromboembolic complications or aneurysmal formation. This murine model will aid us in understanding and quantifying the cellular and molecular mechanisms of neotissue formation in the TEVG.

AB - Biodegradable scaffolds seeded with bone marrow mononuclear cells (BMCs) are often used for reconstructive surgery to treat congenital cardiac anomalies. The long-term clinical results showed excellent patency rates, however, with significant incidence of stenosis. To investigate the cellular and molecular mechanisms of vascular neotissue formation and prevent stenosis development in tissue engineered vascular grafts (TEVGs), we developed a mouse model of the graft with approximately 1 mm internal diameter. First, the TEVGs were assembled from biodegradable tubular scaffolds fabricated from a polyglycolic acid nonwoven felt mesh coated with ε-caprolactone and L-lactide copolymer. The scaffolds were then placed in a lyophilizer, vacuumed for 24 hr, and stored in a desiccator until cell seeding. Second, bone marrow was collected from donor mice and mononuclear cells were isolated by density gradient centrifugation Third, approximately one million cells were seeded on a scaffold and incubated O/N. Finally, the seeded scaffolds were then implanted as infrarenal vena cava interposition grafts in C57BL/6 mice. The implanted grafts demonstrated excellent patency (>90%) without evidence of thromboembolic complications or aneurysmal formation. This murine model will aid us in understanding and quantifying the cellular and molecular mechanisms of neotissue formation in the TEVG.

KW - Biodegradable

KW - Inferior vena cava

KW - Interposition graft

KW - Issue 88

KW - Medicine

KW - Mouse model

KW - Tissue engineered vascular graft

KW - Tissue engineering

UR - http://www.scopus.com/inward/record.url?scp=84929789491&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929789491&partnerID=8YFLogxK

U2 - 10.3791/51632

DO - 10.3791/51632

M3 - Article

C2 - 24961688

AN - SCOPUS:84929789491

JO - Journal of Visualized Experiments

JF - Journal of Visualized Experiments

SN - 1940-087X

IS - 88

M1 - e51632

ER -